calendar
2,458 catalysts · 3,921 phase readout · 2,133 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
2,458 catalysts · 3,921 phase readout · 2,133 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
Items: 2.02, 9.01
Items: 1.01, 3.02, 5.03, 5.07, 9.01
Items: 2.01, 7.01, 9.01
Items: 2.02, 9.01
Items: 5.02, 9.01
Items: 5.02, 9.01
Items: 8.01, 9.01
Items: 2.02, 9.01
Items: 5.02, 5.07, 9.01
Items: 2.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 7.01, 9.01
Items: 5.02, 8.01, 9.01
Items: 8.01, 9.01
Items: 2.02, 5.02
Items: 2.02, 7.01, 9.01
Items: 1.01, 8.01, 9.01
Items: 8.01, 9.01
Items: 5.02, 9.01
Items: 1.01, 2.03, 3.02, 7.01, 9.01
Items: 2.02, 9.01
Anticipated earnings call for Kymera Therapeutics, Inc. ($KYMR).
Anticipated earnings call for Indivior Pharmaceuticals, Inc. ($INDV).
Anticipated earnings call for Organon & Co. ($OGN).
Anticipated earnings call for Amneal Pharmaceuticals, Inc. ($AMRX).
Anticipated earnings call for LINDE PLC ($LIN).
Anticipated earnings call for CHURCH & DWIGHT CO INC /DE/ ($CHD).
Anticipated earnings call for Moderna, Inc. ($MRNA).
Items: 5.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 1.01, 3.02, 5.02, 8.01, 9.01
Items: 1.01, 3.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 9.01
Items: 1.01, 7.01, 9.01
Items: 7.01, 9.01
Items: 5.02
Items: 1.01, 1.02, 2.03, 3.02
Items: 7.01, 8.01, 9.01
Items: 5.03, 9.01
Items: 7.01, 8.01, 9.01
Items: 3.01
Items: 5.07
Items: 1.01, 9.01
Items: 3.01
Items: 5.07, 9.01
Items: 1.01, 2.03, 3.02, 5.01, 9.01
Items: 5.02, 9.01